Modulators of arginine metabolism support cancer immunosurveillance

Giusy Capuano, Nicolò Rigamonti, Matteo Grioni, Massimo Freschi, Matteo Bellone

Research output: Contribution to journalArticle

Abstract

Background: Tumor-associated accrual of myeloid derived suppressor cells (MDSC) in the blood, lymphoid organs and tumor tissues may lead to perturbation of the arginine metabolism and impairment of the endogenous antitumor immunity. The objective of this study was to evaluate whether accumulation of MDSC occurred in Th2 prone BALB/c and Th1 biased C57BL/6 mice bearing the C26GM colon carcinoma and RMA T lymphoma, respectively, and to investigate whether N(G) nitro-L-arginine methyl ester (L-NAME) and sildenafil, both modulators of the arginine metabolism, restored antitumor immunity. Results: We report here that MDSC accumulate in the spleen and blood of mice irrespective of the mouse and tumor model used. Treatment of tumor-bearing mice with either the phosphodiesterase-5 inhibitor sildenafil or the nitric-oxide synthase (NOS) inhibitor L-NAME significantly restrained tumor growth and expanded the tumor-specific immune response. Conclusion: Our data emphasize the role of MDSC in modulating the endogenous tumor-specific immune response and underline the anti-neoplastic therapeutic potential of arginine metabolism modulators.

Original languageEnglish
Article number1
JournalBMC Immunology
Volume10
DOIs
Publication statusPublished - Jan 9 2009

    Fingerprint

ASJC Scopus subject areas

  • Immunology

Cite this